Key result
Medical therapy alone successfully treats a rare case of postpartum native tricuspid valve infective endocarditis.
Why the study?
Native valve infective endocarditis during pregnancy or the peripartum period is a rare entity with significant morbidity and mortality.
Case Report (n=1)
Highlights a rare presentation of post-partum native tricuspid valve infective endocarditis in a patient without traditional risk factors, successfully managed with medical therapy.
May support medical therapy in select rare post-partum tricuspid IE cases; leaves open generalizability and need for prospective data.
Native valve infective endocarditis during pregnancy or the peripartum period is a rare entity with significant morbidity and mortality. Rheumatic heart disease was previously considered a significant risk factor, changing to intravenous drug abuse in recent decades. We hereby report a case of tricuspid native valve endocarditis complicating the peri-partum period in a young female without underlying traditional risk factors, who improved with medical therapy alone.
No takes yet. Share an insight, caveat, or question.
Divyashree et al. (2022) conducted a case report in Post-partum Native Tricuspid Valve Infective Endocarditis (n=1). Medical therapy was evaluated on Clinical improvement. Medical therapy alone successfully treated a rare case of post-partum native tricuspid valve infective endocarditis in a young female without traditional risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: